171 related articles for article (PubMed ID: 1387653)
1. The ovarian contribution to peripherally derived serum C19 conjugates.
Matteri RK; Stanczyk FZ; Cassidenti DL; Paulson RJ; Lobo RA
J Clin Endocrinol Metab; 1992 Sep; 75(3):768-72. PubMed ID: 1387653
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Stanczyk FZ; Saxena T; Lobo RA
J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
[TBL] [Abstract][Full Text] [Related]
3. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
Lobo RA; Goebelsmann U; Horton R
J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
[TBL] [Abstract][Full Text] [Related]
5. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
6. Androsterone sulfate: physiology and clinical significance in hirsute women.
Zwicker H; Rittmaster RS
J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
[TBL] [Abstract][Full Text] [Related]
7. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
Labrie F; Bélanger A; Cusan L; Gomez JL; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2396-402. PubMed ID: 9253307
[TBL] [Abstract][Full Text] [Related]
8. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
9. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen.
Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
Hum Reprod; 1995 Feb; 10(2):299-303. PubMed ID: 7769052
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of plasma adrenocorticotropin in polycystic ovary disease.
Chang RJ; Mandel FP; Wolfsen AR; Judd HL
J Clin Endocrinol Metab; 1982 Jun; 54(6):1265-7. PubMed ID: 6281296
[TBL] [Abstract][Full Text] [Related]
11. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
[TBL] [Abstract][Full Text] [Related]
12. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of C19 steroid glucuronides in pre-menopausal women with non-classical congenital adrenal hyperplasia.
Whorwood CB; Ueshiba H; del Blazo P
J Steroid Biochem Mol Biol; 1992 Apr; 42(2):211-21. PubMed ID: 1314640
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of 5-androstene-3 beta,17 beta-diol sulphate, 5 alpha-androstane-3 alpha, 17beta-diol sulphate and glucuronide, in late onset 21-hydroxylase deficiency.
Montalto J; Funder JW; Yong AB; Whorwood CB; Connelly JF
J Steroid Biochem Mol Biol; 1990 Nov; 37(4):593-8. PubMed ID: 2177625
[TBL] [Abstract][Full Text] [Related]
15. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
[TBL] [Abstract][Full Text] [Related]
16. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
Judd HL; Rigg LA; Anderson DC; Yen SS
J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
[TBL] [Abstract][Full Text] [Related]
17. Ovarian androgen production in postmenopausal women.
Fogle RH; Stanczyk FZ; Zhang X; Paulson RJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3040-3. PubMed ID: 17519304
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
Brochu M; Bélanger A; Tremblay RR
Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
[TBL] [Abstract][Full Text] [Related]
19. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.
Steingold K; De Ziegler D; Cedars M; Meldrum DR; Lu JK; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031
[TBL] [Abstract][Full Text] [Related]
20. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
